Changeflow GovPing Pharma & Drug Safety Xanthommatin Color Additive for Food Beverage a...
Routine Notice Added Draft

Xanthommatin Color Additive for Food Beverage and Drug Compositions

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published December 9th, 2025
Detected April 2nd, 2026
Email

Summary

USPTO published patent application US20260090963A1 by inventor Leila Deravi for xanthommatin as an edible color additive for food, beverage, and drug compositions at 0.01-0.5% wt concentration. The application covers substrates including foods, beverages, drinks, medications, and drug forms.

What changed

The USPTO published patent application US20260090963A1 claiming xanthommatin as an edible color additive for food, beverage, and drug compositions. The invention comprises xanthommatin at a concentration of about 0.01% to 0.5% by weight, optionally combined with dry-based or solution-based carriers, applied to or incorporated into food, beverage, drink, medication, or drug form substrates. The additive can produce colors across the yellow, orange, red, and brown spectrum depending on concentration.

This is a patent application filing only and does not create immediate compliance obligations or regulatory requirements. Manufacturers and developers of food colorants, beverage products, or pharmaceutical formulations may wish to monitor the prosecution of this application to understand potential future intellectual property implications in the natural color additive space.

Source document (simplified)

← USPTO Patent Applications

Xanthommatin as Color Additive for Food, Beverage and Drug Compositions

Application US20260090963A1 Kind: A1 Apr 02, 2026

Inventors

Leila Deravi

Abstract

A substrate having an edible color additive within the substrate or coated on the substrate is disclosed. The edible color additive comprises xanthommatin at a concentration of about 0.01% wt to about 0.5% wt and optionally a dry based carrier or a solution-based carrier. The substrate is a food, beverage, drink, medication or a drug form. The color additives of the disclosure can be produced in the color spectrum of yellow, orange, red, or concentrated forms (e.g., concentrated yellow appears as brown).

CPC Classifications

A61K 8/29 A61K 8/0245 A61K 8/0275 A61K 8/0283 A61K 8/25 A61K 8/26 A61K 8/411 A61K 8/49 A61K 8/73 A61K 8/8152 A61K 8/85 A61K 8/86 A61Q 17/04 A61Q 19/08 C09B 19/00 C09B 61/00 C09B 67/0097 A61K 2800/412 A61K 2800/438 A61K 2800/45 A61K 2800/52 A61K 2800/651 A61K 2800/654

Filing Date

2025-12-09

Application No.

19414228

View original document →

Named provisions

Abstract Inventors CPC Classifications

Classification

Agency
USPTO
Published
December 9th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260090963A1

Who this affects

Applies to
Food manufacturers Drug manufacturers Pharmaceutical companies
Industry sector
3114 Food & Beverage Manufacturing 3254 Pharmaceutical Manufacturing 5112 Software & Technology
Activity scope
Patent Filing
Geographic scope
United States US

Taxonomy

Primary area
Food Safety
Operational domain
Legal
Topics
Consumer Protection Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.